...
首页> 外文期刊>Intestinal research. >Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul
【24h】

Diagnosis of inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization for Crohn's and Colitis (AOCC) meeting in Seoul

机译:亚洲炎症性肠病的诊断:在首尔举行的第二届亚洲克罗恩和结肠炎组织(AOCC)会议上进行的跨国网络调查结果

获取原文
           

摘要

Background/Aims As the number of Asian patients with inflammatory bowel disease (IBD) has increased recently, there is a growing need to improve IBD care in this region. This study is aimed at determining how Asian countries are currently dealing with their IBD patients in terms of diagnosis. Methods A questionnaire was designed by the organizing committee of Asian Organization for Crohn's and Colitis, for a multinational web-based survey conducted between March 2014 and May 2014. Results A total of 353 Asian medical doctors treating IBD patients responded to the survey (114 in China, 88 in Japan, 116 in Korea, and 35 in other Asian countries). Most of the respondents were gastroenterologists working in an academic teaching hospital. While most of the doctors from China, Japan, and Korea use their own national guidelines for IBD diagnosis, those from other Asian countries most commonly adopt the European Crohn's Colitis Organisation's guideline. Japanese doctors seldom adopt the Montreal classification for IBD. The most commonly used activity scoring system for ulcerative colitis is the Mayo score in all countries except China, whereas that for Crohn's disease (CD) is the Crohn's Disease Activity Index. The most available tool for small-bowel evaluation in CD patients differs across countries. Many physicians administer empirical anti-tuberculous medications before the diagnosis of CD. Conclusions The results of this survey demonstrate that Asian medical doctors have different diagnostic approaches for IBD. This knowledge would be important in establishing guidelines for improving the care of IBD patients in this region.
机译:背景/目的随着最近亚洲炎症性肠病(IBD)患者的数量增加,在该地区改善IBD护理的需求日益增长。这项研究旨在确定亚洲国家目前在诊断方面如何应对其IBD患者。方法由亚洲克罗恩氏和结肠炎组织组织委员会设计问卷,以进行2014年3月至2014年5月的跨国网络调查。结果共有353名治疗IBD患者的亚洲医生对此进行了回应(114例中国,日本88个,韩国116个,亚洲其他国家35个)。大多数受访者是在学术教学医院工作的胃肠病学家。尽管来自中国,日本和韩国的大多数医生使用自己的国家IBD诊断指南,但来自其他亚洲国家的医生通常采用欧洲克罗恩结肠炎组织的指南。日本医生很少采用IBD的蒙特利尔分类。溃疡性结肠炎最常用的活动评分系统是除中国以外的所有国家/地区的Mayo评分,而克罗恩病(CD)评分则是克罗恩病活动指数。在CD患者中,最有用的小肠评估工具在不同国家有所不同。在诊断CD之前,许多医生会使用经验性的抗结核药物。结论这项调查的结果表明,亚洲医生对IBD的诊断方法不同。这些知识对于建立改善该地区IBD患者护理的指南至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号